Molecular Partners AG (MOLN)
NASDAQ: MOLN · IEX Real-Time Price · USD
3.745
+0.025 (0.67%)
At close: May 17, 2024, 3:58 PM
3.620
-0.125 (-3.34%)
After-hours: May 17, 2024, 4:00 PM EDT
Molecular Partners AG Revenue
Molecular Partners AG had revenue of $7.64M in the twelve months ending March 31, 2024, down -64.99% year-over-year. Revenue in the quarter ending March 31, 2024 was $3.11M, a -7.17% decrease year-over-year. In the year 2023, Molecular Partners AG had annual revenue of $8.38M, a decrease of -95.89%.
Revenue (ttm)
$7.64M
Revenue Growth
-64.99%
P/S Ratio
16.41
Revenue / Employee
$45,768
Employees
167
Market Cap
125.43M USD
Revenue Chart
* The company reports in CHF currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.38M | -195.49M | -95.89% |
Dec 31, 2022 | 203.87M | 193.15M | 1,802.02% |
Dec 31, 2021 | 10.72M | 100.50K | 0.95% |
Dec 31, 2020 | 10.62M | -10.40M | -49.47% |
Dec 31, 2019 | 21.01M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMOLN News
- 2 days ago - Interim Management Statement Q1 2024 of Molecular Partners: Pipeline Progressing with Two Additional Programs to Enter the Clinic in 2025, Update to MP0533 Program - GlobeNewsWire
- 19 days ago - Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533's Proposed Mechanism of Action - GlobeNewsWire
- 4 weeks ago - Life Science Cares Launches in Switzerland - GlobeNewsWire
- 4 weeks ago - Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting - GlobeNewsWire
- 7 weeks ago - Molecular Partners Publishes Invitation to Annual General Meeting 2024 - GlobeNewsWire
- 2 months ago - Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023 - GlobeNewsWire
- 2 months ago - Molecular Partners Announces Dismissal of Class Action Lawsuit - GlobeNewsWire
- 2 months ago - Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations - GlobeNewsWire